Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2000
03/16/2000CA2342849A1 Methods for generating high titer helper-free preparations of released recombinant aav vectors
03/16/2000CA2342311A1 Novel protein kinase molecules and uses therefor
03/16/2000CA2342124A1 Nucleic acid molecules encoding an amylosucrase
03/16/2000CA2342115A1 Nucleic acid molecules encoding enzymes having fructosyltransferase activity, and their use
03/16/2000CA2341782A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus
03/16/2000CA2341777A1 Neutral amino acid transporter and gene thereof
03/16/2000CA2341762A1 Highly efficient mutagenesis method with the use of psoralen derivatives
03/16/2000CA2341325A1 Method of stimulating prosaposin receptor activity
03/16/2000CA2341302A1 Lim domain protein homolog
03/16/2000CA2340686A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
03/16/2000CA2340331A1 Mutant egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
03/16/2000CA2309212A1 Essential bacterial genes and their use
03/15/2000EP0985732A2 Trimeric chimera protein and collagen matrix containing chimera protein
03/15/2000EP0985730A1 Method for cloning and producing the snaBI restriction endonuclease and purification thereof
03/15/2000EP0985052A1 METHODS AND COMPOSITIONS TO IDENTIFY SWINE GENETICALLY RESISTANT TO F18 $i(E. COLI) ASSOCIATED DISEASES
03/15/2000EP0985045A2 Modulators of morphogen expression and methods of identifying the same
03/15/2000EP0985038A1 Sodium channel receptor
03/15/2000EP0985037A1 Human multiple endocrine neoplasia type 1 protein
03/15/2000EP0985035A2 Dna methyltransferase genomic sequences and antisense oligonucleotides
03/15/2000EP0985030A2 New human ribonuclease
03/15/2000EP0985029A1 Hyaluronic acid derivative based cell culture matrix and biodegradable three-dimensional matrix
03/15/2000EP0985028A2 Transplants for myocardial scars and method and cellular preparations therefor
03/15/2000EP0984984A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
03/15/2000EP0984983A2 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and a kinase domain
03/15/2000EP0984699A1 Method of inhibiting immune system destruction of transplanted viable cells
03/15/2000EP0725816B1 Method for culturing bipolar-adhesion hepatocytes
03/15/2000EP0651812B1 Modular promoter construct
03/15/2000EP0651788B1 Process for co-cultivating a type of cells with liver cells
03/15/2000EP0551325B1 Method of testing for salmonella
03/15/2000EP0434721B1 Viral nucleotide sequences
03/15/2000CN1247568A Fibroblast growth factor homologs
03/15/2000CN1247567A Tumor necrosis factor receptor alfa 6 and receptor beta 6
03/15/2000CN1247565A Nucleic acid sequence encoding beta-C-4-oxygenase from haematococcus pluvialis for biosynthesis of astaxanthin
03/15/2000CN1247564A Method for activating human antigen presenting cells, activated human antigen presenting cells, and use of same
03/15/2000CN1247473A Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
03/15/2000CN1247229A Paddy rice group of preventing rice blast
03/14/2000US6037525 Preparing recombinant plant cells having more uniform expression of foreign genes; providing a cell, transforming the cell with a vector that has two genetically engineered terminals that control gene expression
03/14/2000US6037524 S-adenosyl-L-homocystein hydrolase promoter
03/14/2000US6037523 Nucleotide sequences which are regulatory sequences which control preferential expression of exogenous genes in plants; for tissue preferential expression of genes
03/14/2000US6037520 Human breast carcinoma cell line capable of production of a spontaneously metastasizing tumor in animals for use in anticancer drug testing
03/14/2000US6037462 Nucleic acids sequences with somatic adjustments in the multiple tumor suppressor gene in human cancers; for diagnosis and treatment of human cancer; anticarciongenic agents; antitumor agents
03/14/2000US6037461 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
03/14/2000US6037324 Madcam-1 (mucosal addressin cell adhesion molecule-1); useful in the treatment of inflammatory bowel diseases and other diseases involving leukocyte infiltration of the gastrointestinal tract or other mucosal tissues
03/14/2000US6037177 Method for increasing the efficiency of recombinant AAV production
03/14/2000US6037175 Method and media for enhancing cryopreservation of cells
03/14/2000US6037174 Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
03/14/2000US6037172 Viral transfer plasmid coding heterologous genes
03/14/2000US6037149 Nucleotide sequence coding human interleukin-9; for the diagnosis of sensitivity to allergy and asthma
03/14/2000US6037146 CDNA clone HE8CH90 that encodes a novel 7-transmembrane receptor
03/14/2000US6037125 Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells
03/14/2000US6037119 Screening for modulators of enzyme activity; propagating cells transformed or transfected with nucleotide sequences coding guanosine monophosphate, preparing extracts, screening for modulators
03/14/2000US6036959 HCMV/HSV fusion glycoproteins
03/14/2000US6036954 Polypeptides with sequence
03/14/2000US6036951 Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders
03/14/2000CA2281935A1 Streptomyces avermitilis regulatory genes for increased avermectin production
03/14/2000CA2143335C Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof
03/14/2000CA2123593C Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists
03/14/2000CA2098483C Safe adeno-associated virus 2 vector for gene therapy
03/14/2000CA2071205C Cell surface antigen associated with cellular apoptosis
03/14/2000CA2008817C M-csf monoclonal antibodies that recognize a neutralizing conformational epitope
03/09/2000WO2000013021A1 Methods and materials for diagnosing unstable angina
03/09/2000WO2000012748A1 Organisms for the extracellular production of riboflavin
03/09/2000WO2000012741A2 Inducible expression system
03/09/2000WO2000012740A2 ADENOVIRUSES DELETED IN THE IVa2, 100K AND/OR PRETERMINAL PROTEIN SEQUENCES
03/09/2000WO2000012737A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000WO2000012736A2 A new method of identifying non-host plant disease resistance genes
03/09/2000WO2000012735A2 Transgene assay using stable agrobacterium rhizogenes transformation
03/09/2000WO2000012727A1 Fusion proteins, dna molecules, vectors, and host cells useful for measuring protease activity
03/09/2000WO2000012726A2 Rationally designed heparinases derived from heparinase i and ii
03/09/2000WO2000012725A2 Transgenic amorpha-4,11-diene synthesis
03/09/2000WO2000012723A1 A novel human lysozyme gene, its encoding polypeptide and the method for preparing them
03/09/2000WO2000012722A1 A novel human lysozyme gene, its encoding polypeptide and the method preparing for them
03/09/2000WO2000012721A1 A novel human lysozyme gene, its encoding polypeptide and the method for preparing them
03/09/2000WO2000012720A2 Elongase genes and uses thereof
03/09/2000WO2000012717A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them
03/09/2000WO2000012716A2 MAIZE Ku70 ORTHOLOGUE AND USES THEREOF
03/09/2000WO2000012715A1 Modification of plant fibres
03/09/2000WO2000012710A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
03/09/2000WO2000012709A2 Phelix: a testis-specific protein expressed in cancer
03/09/2000WO2000012706A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
03/09/2000WO2000012703A2 Protein transport-associated molecules
03/09/2000WO2000012702A2 Human genes differentially expressed in colorectal cancer
03/09/2000WO2000012700A1 GENE ENCODING CDw108
03/09/2000WO2000012696A1 Cell specific promoters of uncoupling protein 3
03/09/2000WO2000012688A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
03/09/2000WO2000012685A2 Genes associated with neurotransmitter processing
03/09/2000WO2000012683A2 Stem cells bearing an fgf receptor on the cell surface
03/09/2000WO2000012682A1 Primate embryonic stem cells with compatible histocompatibility genes
03/09/2000WO2000012679A1 Novel ubiquitin ligases as therapeutic targets
03/09/2000WO2000012678A2 Staphylococcus aureus genes and polypeptides
03/09/2000WO2000012562A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES
03/09/2000WO2000012561A1 Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same
03/09/2000WO2000012560A1 Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody
03/09/2000WO2000012559A1 Monoclonal antibodies against s100
03/09/2000WO2000012558A1 Human monoclonal antibodies directed against the islet cell antigen ia-2
03/09/2000WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3
03/09/2000WO2000012546A1 MAMMALIAN elk POTASSIUM CHANNEL GENES
03/09/2000WO2000012544A2 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
03/09/2000WO2000012532A1 Factor 8 homologue nucleic acids, polypeptides, methods, uses
03/09/2000WO2000012531A1 Ratc